Tag: artificial pancreas device system market demand

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Artificial Pancreas Device System Market Size From 2025 to 2034?

In recent times, the market for the Artificial Pancreas Device System has seen substantial growth. It’s estimated that the market will expand from $1.81 billion in 2024 to $2.06 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 13.8%. Factors contributing to this growth during the historic period include an increase in investment inflow, escalated government involvement in clinical studies, a heightened demand for automated glycemic control systems, concerted research and development endeavors by industry participants, and a rise in the elderly population.

Expectations are high for a swift expansion in the market size of the artificial pancreas device system in the upcoming years. It’s forecasted to soar to about $3.46 billion in 2029, achieving a 13.8% compound annual growth rate (CAGR). This growth over the projection period can be credited to the expanding incidence of diabetes, heightened cases of pancreatic cancer, growing rates of diabetes coupled with obesity, surge in demand for minimally invasive (MI) drug delivery systems, and advances in diabetes management technology. The period is set to witness key trends such as technological breakthroughs, surge in research and development pursuits, rise in product approvals, cooperation and alliances, as well as an uptick in tele consultations for follow-up.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

What External and Internal Drivers Are Contributing to the Growth of theArtificial Pancreas Device System Market?

The rise in pancreatic cancer cases is anticipated to stimulate the expansion of the artificial pancreas device system market. Pancreatic cancer, primarily a malignant tumor developing in the pancreas, a gland situated behind the stomach, is affected by an array of factors such as lifestyle, genetics, medical conditions, and the environment. In addition, genetic mutations leading to hereditary pancreatitis, resulting in chronic pancreatic inflammation also plays a role. The artificial pancreas device system (APDS) principally aids those suffering from diabetes in controlling their blood sugar by routinely checking glucose levels and dispensing the necessary insulin. For example, Cancer Australia, a government agency, calculated that in 2023 there were 4,506 new instances of pancreatic cancer, showing an increase from the 3,751 cases recorded in the preceding five years as of March 2024. Thus, the escalating prevalence of pancreatic cancer is propelling the growth of the artificial pancreas device system market.

What Segment Types Define the Artificial Pancreas Device System Market Structure?

The artificial pancreas device systemmarket covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid

3) By End-User: Hospitals; Medical Centers; Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Artificial Pancreas Device System Market?

North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Artificial Pancreas Device System Market?

Leading firms in the artificial pancreas device system market are working on creating autonomous insulin delivery mechanisms aimed at improving diabetes management. This is done by naturalistically tracking blood sugar levels and dispensing the necessary insulin dosage. The goal of these systems is to mimic the functions of a healthy pancreas, thereby alleviating the strain of regular blood sugar checks and manual insulin delivery for diabetes patients. For instance, in May of 2023, Beta Bionics, an American medical equipment manufacture, obtained FDA 510(k) clearance for their iLet Insulin-Only Bionic Pancreas System, which is an autonomous insulin delivery device. This artificial pancreas system is engineered to independently calculate and administer insulin dosages to manage blood glucose levels. Its closed-loop system continually adjusts insulin dispensation based on the user’s glucose levels, which are gauged by an attached continuous glucose monitor (CGM). All that’s required from the user is their body weight and an estimated meal size for the system to autonomously alter insulin dispensation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Is the Definition of the Artificial Pancreas Device System Market?

Artificial pancreas device system (APDS) is a medical technology designed to automate blood glucose control for individuals with diabetes. The system integrates continuous glucose monitoring (CGM) with an insulin pump, and uses a sophisticated algorithm to automatically adjust insulin delivery based on real-time glucose readings. The device aims to mimic the glucose-regulating function of a healthy pancreas, thereby reducing the need for manual blood glucose monitoring and insulin injections, and helping to maintain blood glucose levels within a target range.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Artificial Pancreas Device System Market In 2029?

In recent times, the artificial pancreas device system market has seen a swift expansion. The market size is anticipated to rise from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. The previously observed growth is owing to factors such as increased investment inflow, growing governmental initiatives in clinical research, a rising demand for automated systems for glycemic control, heightened R&D activities by industry stakeholders, and the surge in the elderly population.

What Growth Rate Is Forecasted for the Artificial Pancreas Device System Market by 2029?

The market size of the artificial pancreas device system is predicted to increase dramatically in the upcoming years, reaching $3.48 billion in 2029 with a compound annual growth rate (CAGR) of 13.9%. This growth projected for the forecasted period is due to the rising incidence of diabetes, the growing prevalence of pancreatic cancer, an increase in occurrences of diabetes and obesity, a growing demand for minimally invasive (MI) drug delivery systems, and improvements in diabetes management technology. Key trends for the forecast period encompass technological advancements, heightened research and development efforts, an increase in product approvals, collaborations and partnerships, and a rise in teleconsultancy activities for follow-ups.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Key Companies Are Shaping the Future of the Artificial Pancreas Device System Market?

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

Which Factors Are Driving Demand in the Artificial Pancreas Device System Industry?

The artificial pancreas device system market is predicted to experience growth driven by the rising rate of pancreatic cancer. This type of cancer, which is a malignant tumor that forms in the pancreas, a gland situated behind the stomach, is influenced by an assortment of factors including lifestyle, genetics, medical and environmental aspects, as well as genetic mutations that cause hereditary pancreatitis, resulting in chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily engineered to assist people with diabetes in regulating their blood sugar levels by automatically tracking glucose and administering the necessary insulin dosage. For example, in March 2024, the government agency, Cancer Australia, projected that there were 4,506 new diagnoses of pancreatic cancer in 2023, demonstrating an increase from the 3,751 cases documented over the last five years. Hence, the growing incidence of pancreatic cancer is fueling the expansion of the artificial pancreas device system market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

How Is the Artificial Pancreas Device System Market Segmented by Several Divisions?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid

3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

What are the Emerging Market Trends Driving the Growth of the Artificial Pancreas Device System Industry?

Leading firms in the artificial pancreas device system market are focusing on the creation of automated insulin delivery solutions to improve diabetes control by autonomously tracking glucose levels in the blood and providing the necessary insulin dosage. The aim of these automated insulin delivery systems is to mimic the operational capabilities of a healthy pancreas, thereby alleviating the need for continuous blood sugar checks and manual insulin dosing for people living with diabetes. For example, Beta Bionics, a medical equipment manufacturer based in the US, obtained FDA 510(k) approval in May 2023 for their iLet Insulin-Only Bionic Pancreas System, a device that delivers insulin automatically. This artificial pancreas system is engineered to independently determine and administer insulin dosage to regulate glucose levels in the blood. It operates as a closed-loop system that modifies insulin delivery relying on the user’s glucose levels recorded by an attached continuous glucose monitor (CGM). The system only needs the user’s weight and an estimate of meal size to automatically adjust insulin delivery.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

Which Regions Are Driving Growth in the Artificial Pancreas Device System Market?

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

This Report Delivers Insight On:

1. How big is the artificial pancreas device system market, and how is it changing globally?

2. Who are the major companies in the artificial pancreas device system market, and how are they performing?

3. What are the key opportunities and risks in the artificial pancreas device system market right now?

4. Which products or customer segments are growing the most in the artificial pancreas device system market?

5. What factors are helping or slowing down the growth of the artificial pancreas device system market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the artificial pancreas device system industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the Artificial Pancreas Device System Market’s Growth Trajectory From 2025 To 2034?

Recent years have seen swift growth in the market size of the artificial pancreas device system. The market, which was worth $1.81 billion in 2024, is projected to rise to $2.07 billion in 2025, recording a compound annual growth rate (CAGR) of 14.1%. This notable growth during the historically significant period can be credited to a surge in investments, increasing governmental initiatives devoted to clinical research, a rising demand for automated systems specific to glycemic control, intense R&D activities advanced by industry players, and a boost in the geriatric population.

Anticipated to experience a swift expansion in the coming years, the market size of the artificial pancreas device system is predicted to reach $3.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.9%. This projected growth during the forecast period can be associated with a rise in diabetes prevalence, an escalation in pancreatic cancer cases, an increase in diabetes and obesity incidents, a surge in demand for minimally invasive (MI) drug delivery systems, and advancements in diabetes management technology. The forecast period is also expected to see major trends such as technological innovations, a boost in research and development activities, a rise in product approvals, the growth of partnerships and collaborations, and an increase in tele-consultancy activities for patient follow-up.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Artificial Pancreas Device System Market?

The growth of the artificial pancreas device system market is anticipated to be fueled by the rising incidence of pancreatic cancer. This type of cancer is a harmful tumor that starts in the pancreas, a gland situated behind the stomach. Various factors including lifestyle, genetic attributes, medical history, and environment, along with genetic changes causing hereditary pancreatitis leading to chronic pancreas inflammation, contribute to pancreatic cancer. The primary function of an artificial pancreas device system (APDS) is to assist diabetes patients in managing their blood glucose levels by automatically tracking glucose levels and administering the required insulin dosage. For example, Cancer Australia, a government agency, projected that there were 4,506 new pancreatic cancer diagnoses in 2023, marking an increase from the 3,751 cases recorded over the previous five years. Thus, the escalating incidence of pancreatic cancer is propelling the expansion of the artificial pancreas device system market.

What Segment Types Define the Artificial Pancreas Device System Market Structure?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid

3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Artificial Pancreas Device System Market?

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Artificial Pancreas Device System Market?

Major corporations involved in the artificial pancreas device system market are focusing on the advancement of automated insulin delivery systems. These systems are designed to improve diabetes management by autonomously tracking blood glucose levels and dispensing the required insulin dose. The objective of automated insulin supply systems is to mimic the functioning of a healthy pancreas, consequently alleviating the demand for ongoing monitoring of blood sugar levels and manual insulin injections for people living with diabetes. To illustrate, Beta Bionics, a US medical equipment producer, got FDA 510(k) clearance for the iLet Insulin-Only Bionic Pancreas System in May 2023. This is an automated insulin dispensing device, an artificial pancreas system that independently determines and administers insulin amounts to regulate blood glucose levels. The device is a closed-loop system that adjusts insulin delivery based on the glucose levels recorded by an attached continuous glucose monitor (CGM). It only needs to know the user’s body weight and an estimated meal size to automatically regulate insulin supply.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Is the Definition of the Artificial Pancreas Device System Market?

Artificial pancreas device system (APDS) is a medical technology designed to automate blood glucose control for individuals with diabetes. The system integrates continuous glucose monitoring (CGM) with an insulin pump, and uses a sophisticated algorithm to automatically adjust insulin delivery based on real-time glucose readings. The device aims to mimic the glucose-regulating function of a healthy pancreas, thereby reducing the need for manual blood glucose monitoring and insulin injections, and helping to maintain blood glucose levels within a target range.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theArtificial Pancreas Device System Market?

The artificial pancreas device system market is anticipated to expand due to the rising occurrences of pancreatic cancer. This cancer, a malignant tumor originating in the pancreas – a gland situated behind the stomach, is influenced by various factors including lifestyle, genetic makeup, health conditions, and environment. Genetic mutations leading to hereditary pancreatitis, which can cause prolonged inflammation of the pancreas, are also contributory factors. An artificial pancreas device system (APDS) is principally created to aid those suffering from diabetes in monitoring their glucose levels and administering suitable insulin doses. In support of this, data from Cancer Australia – a government agency, showed that as of March 2024, the cases of pancreatic cancer diagnosed in 2023 had increased to 4,506 from 3,751 in the last five years. Hence, the rising cases of pancreatic cancer are promoting the growth of the artificial pancreas device system market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

#How Will the CAGR of the Artificial Pancreas Device System Market Influence Its Overall Growth by 2034?

The market for artificial pancreas device systems has experienced significant expansion in the past few years. The market is projected to increase from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this growth during the historic period include an surge in investment, enhanced government participation in clinical research, a rising demand for automated glycemic control systems, sustained research and development activities from industry stakeholders, and a growing elderly population.

Expectations are high for the artificial pancreas device system market to experience quick expansion in the coming years. By 2029, projections indicate a growth to a hefty $3.48 billion, following a compound annual growth rate (CAGR) of 13.9%. This predicted growth within the forecast period can be accredited to the escalating prevalence of conditions such as diabetes and pancreatic cancer, as well as an increase in instances of diabetes and obesity. Other factors contributing to this growth include the rising demand for minimally invasive drug delivery systems and innovation in diabetes management technology. Furthermore, significant trends expected to be seen during the forecast period encompass technological advances, boosted research and development endeavours, a rise in product approvals, an acceleration of collaborations and partnerships, and an upsurge in teleconsultation activity for patient follow-ups.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

Which Upcoming Market Trends and Innovations Are Set to Influence theArtificial Pancreas Device System Market’s Path Forward?

Top firms involved in the artificial pancreas device system market are working towards creating automated insulin delivery systems. These systems are designed to improve diabetes management by autonomously tracking blood sugar levels and administering the required dose of insulin, replicating the role of a healthy pancreas. They aim to alleviate the inconvenience of regularly monitoring blood sugar levels and dispensing insulin manually for diabetics. For example, in May 2023, Beta Bionics, a medical equipment producer based in the US, gained FDA 510(k) approval for their iLet Insulin-Only Bionic Pancreas System. This automated insulin delivery device is an artificial pancreas system that self-regulates and delivers insulin doses to maintain regular blood glucose levels. Acting as a closed-loop system, it adjusts insulin delivery depending on the user’s glucose levels, as tracked by an attached continuous glucose monitor (CGM). The system only needs the user’s body weight and an estimated meal size to adapt the insulin delivery automatically.

Who Are the Dominant Market Players Pushing the Boundaries of theArtificial Pancreas Device System Market?

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Are the Core Segments of the Artificial Pancreas Device System Market, and How Do They Contribute to Growth?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid

3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

What Regions Are Dominating the Artificial Pancreas Device System Market Growth?

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2025, By The Business Research Company:

Automotive Artificial Intelligence Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

Artificial Intelligence in Military Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-military-global-market-report

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the artificial pancreas device system market grown over the years?

The artificial pancreas device system market has experienced strong growth in recent years. It is expected to rise from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Contributing factors include rising investment inflows, growing government initiatives in clinical research, higher demand for automated glycemic control systems, intensive R&D by industry players, and an expanding elderly population.

What Is the forecasted market size and growth rate for the artificial pancreas device system market?

The artificial pancreas device system market is anticipated to grow rapidly, reaching $3.48 billion by 2029, at a CAGR of 13.9%. Factors contributing to this growth include the rising incidence of diabetes and pancreatic cancer, the increased demand for minimally invasive drug delivery systems, and ongoing innovations in diabetes management technology. Trends include technological breakthroughs, growing research efforts, increased product approvals, and the rise in teleconsultancy for follow-up care.

Get your artificial pancreas device system market report here!

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What are the major factors driving growth in the artificial pancreas device system market?

The artificial pancreas device system market is expected to grow due to the increasing prevalence of pancreatic cancer. Pancreatic cancer, influenced by lifestyle, genetic, and environmental factors, is becoming more common. Artificial pancreas systems help diabetes patients manage blood sugar levels by automatically monitoring glucose and delivering insulin. Cancer Australia reported an increase in pancreatic cancer cases in 2023, with 4,506 new diagnoses, up from 3,751 over the previous five years. This rise in cases will further propel the demand for artificial pancreas systems.

What key areas define the segmentation of the global artificial pancreas device system Market?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid

3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

What are the top market players propelling the growth of the artificial pancreas device system industry?

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

What are the key trends shaping the future of the artificial pancreas device system market?

In the artificial pancreas device system market, companies are developing automated insulin delivery systems to improve diabetes management by continuously monitoring blood glucose levels and automatically administering insulin. These systems aim to reduce the burden of manual blood sugar monitoring and insulin injection. For example, in May 2023, Beta Bionics, a US-based medical device company, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System. This device autonomously adjusts insulin doses based on glucose levels, providing more precise and convenient diabetes management for users.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

What regions are dominating the artificial pancreas device system market growth?

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Automotive Artificial Intelligence Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

Artificial Intelligence in Military Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-military-global-market-report

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Anticipated Growth Speed of the Artificial Pancreas Device SystemMarket Between 2024 and 2033?

The artificial pancreas device system market has expanded rapidly, growing from $1.59 billion in 2023 to $1.81 billion in 2024, with a CAGR of 13.9%. Key drivers include increased investments, government initiatives in clinical research, growing demand for automated glycemic control systems, intensive R&D efforts, and a rising elderly population.

The artificial pancreas device system market is projected to experience rapid growth, expected to reach $3.06 billion by 2028 at a CAGR of 14%. This growth is driven by the rising prevalence of diabetes and pancreatic cancer, increasing obesity rates, growing demand for minimally invasive drug delivery systems, and innovations in diabetes management technology. Major trends include technological innovations, increased R&D activities, product approvals, partnerships and collaborations, and enhanced teleconsultancy services for follow-up care.

Which Factors Are Enhancing the Growth of the Artificial Pancreas Device System Market?

The increasing prevalence of pancreatic cancer is expected to propel the growth of the artificial pancreas device system market going forward. Pancreatic cancer is a malignant tumor that originates in the pancreas, a gland located behind the stomach. Pancreatic cancer is influenced by a combination of lifestyle, genetic, medical, and environmental factors, along with genetic mutations causing hereditary pancreatitis, which can lead to chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to help individuals with diabetes manage their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin.

Claim Your Free Sample of the Global Artificial Pancreas Device System Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Segments Are Crucial in the Artificial Pancreas Device System Market?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users

What Emerging Trends Are Shaping the Future of the Artificial Pancreas Device System Market?

Companies in the artificial pancreas device system market are developing automated insulin delivery systems. Beta Bionics received FDA clearance for the iLet Insulin-Only Bionic Pancreas System in May 2023, enabling autonomous insulin delivery.

Order Now for Fast Delivery of Your Artificial Pancreas Device System Market Report!

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Regions Are At the Forefront of Artificial Pancreas Device System Market Expansion?

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Artificial Pancreas Device System Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the artificial pancreas device system market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Artificial Pancreas Device System Market Include

1. Artificial Pancreas Device System Market Executive Summary
2. Artificial Pancreas Device System Market Segments
3. Artificial Pancreas Device System Market Size And Template Market Growth Rate
4.  Key Artificial Pancreas Device System Market Trends
5. Major Artificial Pancreas Device System Market Drivers
……
25. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market
26. Top Artificial Pancreas Device System Companies
27. Artificial Pancreas Device System Market Opportunities And Strategies
28. Artificial Pancreas Device System Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Artificial Intelligence in Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

Artificial Turf Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-turf-global-market-report

Refrigerators Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerators-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The artificial pancreas device system market size has grown rapidly in recent years, expanding from $1.59 billion in 2023 to $1.81 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. This historical growth has been driven by factors such as increased investment inflows, government initiatives in clinical research, a growing demand for automated glycemic control systems, intensive R&D efforts by industry players, and a rising geriatric population. Moving forward, the market is projected to grow to $3.06 billion in 2028 at a CAGR of 14%. Key drivers for this growth include the growing prevalence of diabetes, increasing occurrences of pancreatic cancer, the rising prevalence of diabetes and obesity, a higher demand for minimally invasive drug delivery systems, and technological advancements in diabetes management. Major trends during the forecast period will likely include innovations in technology, increasing research and development activities, more product approvals, partnerships and collaborations, and enhanced tele-consultancy activities for follow-up care.

The increasing prevalence of pancreatic cancer is expected to propel the growth of the artificial pancreas device system market going forward. Pancreatic cancer is a malignant tumor that originates in the pancreas, a gland located behind the stomach. Pancreatic cancer is influenced by a combination of lifestyle, genetic, medical, and environmental factors, along with genetic mutations causing hereditary pancreatitis, which can lead to chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to help individuals with diabetes manage their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For instance, in March 2024, Cancer Australia, a government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, an increase from the 3,751 cases reported over the past five years. Therefore, the increasing prevalence of pancreatic cancer is driving the growth of the artificial pancreas device system market.

Get A Free Sample On The Artificial Pancreas Device System Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

What Are The Key Trends That Influence Artificial Pancreas Device System Market Share Analysis?

Major companies operating in the artificial pancreas device system market are developing automated insulin delivery systems to enhance diabetes management by automatically monitoring blood glucose levels and delivering the appropriate amount of insulin. Automated insulin delivery systems aim to replicate the function of a healthy pancreas, reducing the burden of constant blood sugar monitoring and manual insulin administration for individuals with diabetes. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturing company, received FDA 510(k) clearance for iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. It is an artificial pancreas system designed to autonomously determine and deliver insulin doses to control blood glucose levels. A closed-loop system automatically adjusts insulin delivery based on the user’s glucose levels measured by a connected continuous glucose monitor (CGM). It only requires the user’s body weight and a meal size estimate to adjust insulin delivery automatically.

How Is The Global Artificial Pancreas Device System Market Segmented?

1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
3) By End-User: Hospitals; Medical Centers; Other End-Users

Read The Full Artificial Pancreas Device System Market Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

The Artificial Pancreas Device System Global Market Report 2024 provides an overview of the artificial pancreas device system market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The artificial pancreas device system market forecast analyzes artificial pancreas device system market size, artificial pancreas device system market share, leading competitor and their market positions.

The Table Of Content For The Artificial Pancreas Device System Market Include:

Explore Similar Reports From The Business Research Company:

Pancreatic Cancer Diagnostic Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Pancreatic Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Artificial Organ Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: